Results Snapshot
Figures in Cr
Consolidated - Profit And Loss Results
Mar'26
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
No of Months
12
12
12
12
12
12
Operating Income
7,344.00
6,672.00
6,228.00
5,652.00
5,305.00
5,393.00
Less :Inter divisional transfers
0.00
0.00
0.00
0.00
0.00
0.00
Less: Excise
0.00
0.00
0.00
0.00
0.00
0.00
Net Sales
7,344.00
6,672.00
6,228.00
5,652.00
5,305.00
5,393.00
Expenditure (Ex Depriciation)
Stock Adjustments
-271.00
-289.00
-142.00
78.00
-43.00
-193.00
Raw Materials Consumed
2,256.00
2,083.00
1,857.00
1,630.00
1,489.00
1,451.00
Power & Fuel Cost
177.00
179.00
173.00
151.00
120.00
118.00
Employee Cost
1,731.00
1,562.00
1,446.00
1,169.00
1,133.00
1,051.00
Operating Expenses
469.00
431.00
366.00
380.00
328.00
346.00
General and Administration Expenses
-1.00
-1.00
-1.00
-1.00
-1.00
-1.00
Selling and Distribution Expenses
1,083.00
1,064.00
996.00
952.00
890.00
696.00
Cost of Software developments
0.00
0.00
0.00
0.00
0.00
0.00
Miscellaneous Expenses
59.00
46.00
50.00
60.00
47.00
-44.00
Expenses Capitalised
0.00
0.00
0.00
0.00
0.00
0.00
Total Expenditure
6,226.00
5,663.00
5,295.00
4,944.00
4,431.00
3,835.00
Operating Profit (PBDIT) excl Other Income
1,118.00
1,008.00
933.00
708.00
874.00
1,557.00
Other Income
54.00
42.00
28.00
2.00
50.00
10.00
Operating Profit (PBDIT)
1,172.00
1,050.00
961.00
711.00
924.00
1,567.00
Interest
93.00
78.00
56.00
50.00
17.00
16.00
Profit before Depriciation and Tax
1,079.00
972.00
905.00
660.00
906.00
1,551.00
Depreciation
318.00
278.00
272.00
275.00
286.00
183.00
Profit Before Taxation & Exceptional Items
760.00
693.00
632.00
385.00
620.00
1,368.00
Exceptional Income / Expenses
0.00
0.00
0.00
0.00
0.00
0.00
Profit Before Tax
693.00
707.00
631.00
354.00
625.00
1,368.00
Provision for Tax
23.00
125.00
16.00
12.00
104.00
253.00
Profit After Tax
670.00
581.00
616.00
372.00
515.00
1,114.00
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
Adj to Profit After Tax
0.00
0.00
0.00
0.00
0.00
0.00
Profit Balance B/F
4,394.00
4,027.00
3,568.00
2,554.00
2,384.00
1,538.00
Profit Available for appropriations
5,068.00
4,610.00
4,184.00
2,896.00
2,905.00
2,716.00
Appropriations
5,068.00
4,610.00
4,184.00
2,896.00
2,905.00
2,716.00
Equity Dividend (%)
600.00%
550.00%
550.00%
400.00%
500.00%
700.00%
Earnings Per Share
34.33
29.68
31.33
17.40
26.50
60.81
Profit And Loss Analysis Highlights
Net Sales
YoY Growth in year ended Mar 2026 is 10.08% vs 7.12% in Mar 2025
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Mar 2026 is 10.93% vs 8.02% in Mar 2025
Interest
YoY Growth in year ended Mar 2026 is 18.87% vs 40.19% in Mar 2025
Profit After Tax
YoY Growth in year ended Mar 2026 is 15.39% vs -5.78% in Mar 2025
Compare Profit and Loss Results of Alembic Pharma
Figures in Cr
consolidated - Profit And Loss Results
Change(INR)
Change(%)
No of Months
12
12
Operating Income
7,344.00
5,365.00
1,979.00
36.89%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
7,344.00
5,365.00
1,979.00
36.89%
Expenditure (Ex Depriciation)
Stock Adjustments
-271.00
-224.00
-47.00
-20.98%
Raw Materials Consumed
2,256.00
2,099.00
157.00
7.48%
Power & Fuel Cost
177.00
128.00
49.00
38.28%
Employee Cost
1,731.00
888.00
843.00
94.93%
Operating Expenses
469.00
308.00
161.00
52.27%
General and Administration Expenses
-1.00
-1.00
0.00
0.00%
Selling and Distribution Expenses
1,083.00
333.00
750.00
225.23%
Cost of Software developments
0.00
12.00
-12.00
-100.00%
Miscellaneous Expenses
59.00
59.00
0.00
0.00%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
6,226.00
4,180.00
2,046.00
48.95%
Operating Profit (PBDIT) excl Other Income
1,118.00
1,185.00
-67.00
-5.65%
Other Income
54.00
20.00
34.00
170.00%
Operating Profit (PBDIT)
1,172.00
1,205.00
-33.00
-2.74%
Interest
93.00
114.00
-21.00
-18.42%
Profit before Depriciation and Tax
1,079.00
1,091.00
-12.00
-1.10%
Depreciation
318.00
296.00
22.00
7.43%
Profit Before Taxation & Exceptional Items
760.00
794.00
-34.00
-4.28%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
693.00
784.00
-91.00
-11.61%
Provision for Tax
23.00
189.00
-166.00
-87.83%
Profit After Tax
670.00
595.00
75.00
12.61%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
4,394.00
3,059.00
1,335.00
43.64%
Profit Available for appropriations
5,068.00
3,654.00
1,414.00
38.70%
Appropriations
5,068.00
3,654.00
1,414.00
38.70%
Equity Dividend (%)
600%
175%
425.00
Earnings Per Share
34.33
24.47
9.86
40.29%
Profit And Loss - Net Sales
Net Sales 7,344.90 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 10.08% vs 7.12% in Mar 2025
Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 1,118.46 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 10.93% vs 8.02% in Mar 2025
Profit And Loss - Interest
Interest 93.63 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 18.87% vs 40.19% in Mar 2025
Profit And Loss - Profit After Tax
Profit After Tax 670.58 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 15.39% vs -5.78% in Mar 2025